<h1>Nath Bio-Genes to Convene Board Meeting to Approve Unaudited Financial Results for Quarter Ended June 30, 2026</h1>
Nath Bio-Genes (India) Ltd has scheduled a meeting of its Board of Directors to consider and approve the Unaudited Financial Results of the company for the quarter ending June 30, 2026.
The board meeting is set to take place on Wednesday, July 29, 2026. The agenda includes considering and taking on record the Unaudited Financial Results in both standalone and consolidated format for the specified period. Members of the board will also transact any other business with the permission of the Chairperson.
In operational updates related to trading, Nath Bio-Genes announced that its "Trading Window" has been closed since June 30, 2026, adhering to the Code of Conduct for Prevention of Insider Trading. The company stated that the trading window will remain shut until 48 hours after the declaration of the financial results. Accordingly, the trading window is scheduled to reopen on August 1, 2026.
NATHBIOGEN Stock Price Movement
On Friday, Nath Bio-Genes (India) Limited shares edged higher to close at ₹160.04, recording a gain of 0.65%. The stock saw activity on a volume of 8,491 shares during the trading session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.